nimotuzumab
biocon,oncoscience,daiichi sankyo
['nimotuzumab']
 . explains more about the curious history of nimotuzumab here: 
Mark Lewis, MD, (@marklewismd) #GISM Oncologist from @Intermountain, takes over our Twitter today to discuss #ASCO22.